| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |